Literature DB >> 22208542

Glutaraldehyde-induced colitis: case reports and literature review.

Hsiang-Yao Shih1, Deng-Chyang Wu, Wan-Ting Huang, Yong-Yu Chang, Fang-Jung Yu.   

Abstract

Glutaraldehyde-induced colitis is an uncommon colitis in clinical practice. Because the involvement of colonic segment is determined by the endoscopic part where glutaraldehyde remains, a recent history of endoscopy and a demarcated involvement of colonic segment are the most characteristic signs of glutaraldehyde-induced colitis. The typical clinical scenario is acute onset of lower abdominal pain, fever, and bloody stool. Laboratory data usually show leukocytosis and elevated C-reactive protein. The endoscopic pictures of involved segments are compatible with acute colitis, including hyperemic, edematous, with or without multiple erosions. Acute ischemic colitis and infectious colitis should be differentiated at the outset of the disease. Stool pathogen tests are usually negative. Parenteral empiric antibiotic may be considered if severe transmural edema of the involved segment is observed in computed tomography. Conservative treatment, including bowel rest and parenteral hydration, is able to stabilize the condition in a week. Herein, we present two cases of acute proctocolitis caused by glutaraldehyde after uneventful colonoscopy.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22208542     DOI: 10.1016/j.kjms.2011.06.036

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  2 in total

Review 1.  Use of ethylene-oxide gas sterilisation to terminate multidrug-resistant bacterial outbreaks linked to duodenoscopes.

Authors:  Lawrence F Muscarella
Journal:  BMJ Open Gastroenterol       Date:  2019-08-05

2.  Successful Conservative Treatment of an Elderly Patient with Corrosive Proctocolitis.

Authors:  Chalerm Eurboonyanun; Somchai Ruangwannasak; Kulyada Eurboonyanun; Anan Sripanuskul
Journal:  Case Rep Surg       Date:  2019-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.